Alpha Paradigm Partners, LLC Pfizer Inc Transaction History

Alpha Paradigm Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $860,015 - $1.05 Million	19,653 New	19,653 $860,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $660,767 - $818,773	-14,443 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $1.17 Million - $1.73 Million	-28,222 Reduced 66.15%	14,443 $853 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $1.45 Million - $1.86 Million	36,904 Added 640.58%	42,665 $1.84 Billion
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $206,877 - $234,357	5,761 New	5,761 $226 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.